We look forward to helping you achieve your goals of looking and feeling your best.
Modified GRF, which researchers have suggested may be a potent GHRH analog, may have impacts beyond growth hormone release
In May 2026, Phase 3 topline results from the TRIUMPH-1 trial across 2,339 participants showed an average 28.3 percent body weight reduction over 80 weeks at the highest dose, with 45.3 percent of those participants losing at least 30 percent of body weight a threshold previously achievable only through surgery
In addition, a tiny glass transition signal was also observed in the DSC chart, indicating that the solution contains unfrozen compartment (Fig
Oral Wegovy Weight Loss Results Oral wegovy effectiveness has been demonstrated in clinical trials, showing significant weight loss in adults with obesity
Changes from baseline with retatrutide were compared to those with placebo and dulaglutide